Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David S Carter

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Nature Microbiology|September 6, 2022
Discovery of an orally active benzoxaborole prodrug effective in the treatment of Chagas disease in non-human primatesAngel M Padilla, Wei Wang, Tsutomu Akama, et al.
Bioorganic & Medicinal Chemistry Letters|October 29, 2008
Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitorsLinda M Bannwart, David S Carter, Hai-Ying Cai, et al.
Life Science Alliance|November 21, 2018
Discovery of a cofactor-independent inhibitor of <i>Mycobacterium tuberculosis</i> InhAYi Xia, Yasheen Zhou, David S Carter, et al.
ACS Infectious Diseases|December 27, 2019
Macrofilaricidal Benzimidazole-Benzoxaborole Hybrids as an Approach to the Treatment of River Blindness: Part 1. Amide Linked AnalogsTsutomu Akama, Yvonne R Freund, Pamela W Berry, et al.
Journal of Medicinal Chemistry|November 8, 2013
Discovery of N-[4-[6-tert-butyl-5-methoxy-8-(6-methoxy-2-oxo-1H-pyridin-3-yl)-3-quinolyl]phenyl]methanesulfonamide (RG7109), a potent inhibitor of the hepatitis C virus NS5B polymeraseFrancisco X Talamas, Sarah C Abbot, Shalini Anand, et al.
Journal of Medicinal Chemistry|February 8, 2019
Boron-Pleuromutilins as Anti- Wolbachia Agents with Potential for Treatment of Onchocerciasis and Lymphatic FilariasisRobert T Jacobs, Christopher S Lunde, Yvonne R Freund, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Nature Microbiology|September 6, 2022
Discovery of an orally active benzoxaborole prodrug effective in the treatment of Chagas disease in non-human primatesAngel M Padilla, Wei Wang, Tsutomu Akama, et al.
Bioorganic & Medicinal Chemistry Letters|October 29, 2008
Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitorsLinda M Bannwart, David S Carter, Hai-Ying Cai, et al.
Life Science Alliance|November 21, 2018
Discovery of a cofactor-independent inhibitor of <i>Mycobacterium tuberculosis</i> InhAYi Xia, Yasheen Zhou, David S Carter, et al.
ACS Infectious Diseases|December 27, 2019
Macrofilaricidal Benzimidazole-Benzoxaborole Hybrids as an Approach to the Treatment of River Blindness: Part 1. Amide Linked AnalogsTsutomu Akama, Yvonne R Freund, Pamela W Berry, et al.
Journal of Medicinal Chemistry|November 8, 2013
Discovery of N-[4-[6-tert-butyl-5-methoxy-8-(6-methoxy-2-oxo-1H-pyridin-3-yl)-3-quinolyl]phenyl]methanesulfonamide (RG7109), a potent inhibitor of the hepatitis C virus NS5B polymeraseFrancisco X Talamas, Sarah C Abbot, Shalini Anand, et al.
Journal of Medicinal Chemistry|February 8, 2019
Boron-Pleuromutilins as Anti- Wolbachia Agents with Potential for Treatment of Onchocerciasis and Lymphatic FilariasisRobert T Jacobs, Christopher S Lunde, Yvonne R Freund, et al.
Pageof 2